Delivery Order SPE2DB20D1100-SPE2DB25FD9W4
- Not listed
- The Defense Logistics Agency (DLA) awarded a $30,552.77 delivery order to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 mL vials on July 29, 2025, with a completion date of July 30, 2025. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,478.99 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 mL vials. The contract was competitively awarded without set-aside provisions and is scheduled for completion by August 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a continuation of the company's pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $6,129.70 to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply fulfillment under AmerisourceBergen's broader relationship with the federal government. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of the...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The $5,235.60 contract is for the supply of 4565978324 BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract has an ultimate completion date of October 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order valued at $17,337.60 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The order is for the supply of BRIDION 200 MG/2 ML VIAL 2ML, a specialty pharmaceutical product. This delivery order is issued under an existing Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of...
- The Defense Logistics Agency awarded a $19,114.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials, with an ultimate completion date of August 4, 2025. This non-set-aside award represents a competitively awarded delivery order under AmerisourceBergen's existing contract vehicle with DLA. The pharmaceutical product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania, supporting federal medical procurement needs within...
- The Defense Logistics Agency awarded a delivery order valued at $8,288.57 to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 ml vials on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $20,061.21 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 mL vials on July 23, 2025, with completion scheduled for July 24, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its corporate office location. This...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on July 29, 2025, for Bridion 500 mg/5 mL vials, with a ceiling value of $35,252.62 under firm fixed-price terms. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This competitively awarded, non-set-aside delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $9,692.64 to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 mL vials on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed price, non-set-aside contract with performance to be conducted in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD9W4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $34,538.93 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 mL vials. This competitively awarded, firm fixed-price contract was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. No set-aside designation was applied to this procurement. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor agreement enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and medical commodities across multiple therapeutic domains. The DLA recognizes AmerisourceBergen's capability to meet federal medical procurement requirements through competitive award processes and leverages the company's extensive pharmaceutical distribution network to support Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.5k | 8/11/25 |